Skip to content

Eli Lilly LLY Net Income

Net Income at other companies

Pfizer logo
PfizerPFE
$2.69B-9.4%
Amgen logo
AmgenAMGN
$1.82B+5.1%
Cardinal Health logo
Cardinal HealthCAH
$399M-21.1%
Biogen logo
BiogenBIIB
$319.5M+32.8%
Mannkind logo
MannkindMNKD
-$16.62M-226%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$31.82M-51.5%

Segments

By segment

See full
Reportable Segment$7.4B+168%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$1.01T+46.9%
Enterprise value$1.04T+44.9%
P/E39.8×-21.9×
P/S13.9×-0.1×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's net income?
Eli Lilly (LLY) reported net income of $7.4B in Q1 2026.
How has Eli Lilly's net income changed year-over-year?
Eli Lilly's net income increased by 168.1% year-over-year, from $2.76B to $7.4B.
What is the long-term trend for Eli Lilly's net income?
Over 4 years (2021 to 2025), Eli Lilly's net income has grown at a 38.7% compound annual growth rate (CAGR), from $5.58B to $20.64B.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.